fbpx

View This Webinar on The Transcreener Method For Screening and Profiling GTPases

RhoC Assay - A Transcreener GDP Assay Application

Transcreener GDP Assay directly measures GDP produced by RhoC (Ras homolog family member C). These GDP measurements allow researchers to effectively determine the activity of the RhoC enzyme. The assay provides a powerful tool to screen compound libraries for RhoC modulators to help find new therapies for disease.

The kit comes complete with the detection reagents required to measure activity. RhoC enzyme is not included in the inhibitor screening assay kit. Please contact us for questions related to acquiring the enzyme.

This assay is designed to be used with purified enzyme preparations. Transcreener assays are not validated with cell lysates, blood, serum, or other biological samples.

RhoC Enzyme Reaction Cycle

RhoC Assay On Off Schematic

How Does This RhoC Assay Work?

The Transcreener RhoC Assay determines RhoC enzyme activity by directly measuring the GDP formed by the enzyme using the Transcreener GDP Assay. By detecting GDP output, the assay provides a universal method to assess the activity of any GDP-producing enzyme in real time. 

Transcreener RhoC Assay technology uses a simple but highly effective method that consists of an antibody selective to GDP and a far-red fluorescent tracer. GDP produced in the reaction competes with the tracer changing the fluorescent properties and providing fluorescent readout.

The RhoC assay is available with FP, FI, and TR-FRET readouts and is an easy-to-use mix-and-read format. Perform your enzyme reaction, add the detection reagent, and measure. The simplicity of the system yields robust results that also make it extremely amiable to HTS.

Direct Detection of GDP to Measure RhoC Enzymatic Activity

Fluorescent Polarization (FP)

Transcreener RhoC Assay Schematic

The workhorse. Used in many large screens. Best deck and signal stability.

Fluorescent Intensity (FI)

Transcreener KRAS FI Readout

Positive FI signal. Compatible with simple fluorescence plate readers. Faster read time than FP or TR-FRET.

Time-Resolved Förster Resonance Energy Transfer (TR-FRET)

Transcreener KRAS Assay TR-FRET Readout

For customers who prefer TR-FRET detection. Uses the same filter set as HTRF®.

Applications

  • Measure Enzymatic Activity of RhoC
  • Screen Compound Libraries for RhoC Modulators
  • Quantify Inhibitor Potency
  • Inhibitor Selectivity Profiling
  • Measure Drug-Target Residence Time

Features

  • Direct detection of unlabeled GDP
  • Easy to use, homogenous, one-step format
  • Robust Assay Z’ > 0.7 under initial velocity conditions
  • Far-red fluorescent readouts minimize compound interference
  • A safe, non-radioactive method
  • Available in FP, FI, or TR-FRET readouts

Easy-to-Use, Mix-and-Read, HTS-Ready Assay

Run your enzyme reaction, add Transcreener reagents, and read your plates. The RhoC assay is compatible with 96, 384, and 1536-well formats.

Transcreener Mix and Read Assay

Detection of GDP Released By RhoC (EDTA Concentration Dependence)

EDTA enhances the GDP exchange and GTP hydrolysis of some GTPases. The assay conditions below are chosen to generate the best assay window and ability to study the enzyme. The assay demonstrates linearity when raw data is converted to GDP using a standard curve. Here we use 2 µM GTP. The enzyme buffer includes 20 mM Tris pH 7.5, 75 mM NaCl, 5 mM MgCl2, 0.1 mg/mL BSA, and 1 mM DTT. The Detection mix included 10 μg/mL GDP antibody and 4 nM GDP Alexa 633 tracer. The RhoC enzyme reaction took place for 60, 120, and 180 minutes. The Detection Mix was added with the substrate to start the reaction and incubated at 30°C. Readings were taken with a CLARIOstar plate reader.

RhoC Enzyme Titration

RhoC Enzyme Titration Concentration Dependence

Linear Response

Linear Response Curve RhoC Assay Concentration Dependence

Optimal Assay Conditions: 150 nM RhoC for 2 hours with 20 mM EDTA achieves >150 mP assay window and <20% conversion

Detection of GDP Released By RhoC (Time Dependence)

The assay demonstrates linearity when raw data is converted to GDP using a standard curve. Here we use 2 µM GTP. The enzyme buffer includes 20 mM Tris pH 7.5, 75 mM NaCl, 5 mM MgCl2, 0.1 mg/mL BSA, and 1 mM DTT. The Detection mix included 10 μg/mL GDP antibody and 4 nM GDP Alexa 633 tracer. 20 mM EDTA was used based on the concentration dependent curve. The RhoC enzyme reaction took place for 60, 120, and 180 minutes. The Detection Mix was added with the substrate to start the reaction and incubated at 30°C. Readings were taken with a CLARIOstar plate reader.

RhoC Enzyme Titration

RhoC Enzyme Titration Time Dependence

Linear Response

Linear Response Curve RhoC Assay Time Dependence

Optimal Assay Conditions: 150 nM RhoC for 2 hours with 20 mM EDTA achieves >150 mP assay window and <20% conversion

RhoC Assay Services

Interested in moving your program forward, but don't want to bring an assay in-house? Our scientists can help! BellBrook scientists will use their extensive biochemistry and enzymology expertise to work with you and accelerate your RhoC program (right here in Madison, Wisconsin). We can provide modulator potency profiling for RhoC, along with a variety of other GTPase enzymes, related GAPs, GEFs, and other proteins. Get accurate IC50 results fast to understand how your lead molecule interacts with other GTPases. 

Assay Development Services

Contact Us to Learn More

Contact us today to see if BellBrook's RhoC profiling services will advance your research. We will respond quickly to get the conversation moving and learn how we can help. We keep things discrete, confidential, and professional.

Far-Red FP, FI & TR-FRET Readouts Validated on Major Multimode Readers

SupplierInstrumentFP AssaysFI AssaysTR-FRET Assays
TriStar2S LB 942In ReviewClick Me ArrowValidatedClick Me ArrowValidated
Tristar 5In ReviewClick Me ArrowValidatedIn Review
Mithras2 LB 943In ReviewClick Me ArrowValidatedClick Me ArrowValidated
CytationTM 5ValidatedValidatedValidated
CytationTM 3ValidatedValidatedValidated
CytationTM 1ValidatedValidatedValidated
SynergyTM H1ValidatedValidatedValidated
SynergyTM 2/H4/4Click Me ArrowValidatedClick Me ArrowValidatedClick Me ArrowValidated
SynergyTM HTXNot CapableValidatedNot Capable
SynergyTM Neo 2ValidatedValidatedValidated
POLARstar® OmegaClick Me ArrowValidatedClick Me ArrowValidatedClick Me ArrowValidated
FLUOstar® OmegaNot CapableClick Me ArrowValidatedClick Me ArrowValidated
PHERAstar® FSXClick Me ArrowValidatedClick Me ArrowValidatedClick Me ArrowValidated
PHERAstar® Plus/FSClick Me ArrowValidatedClick Me ArrowValidatedClick Me ArrowValidated
CLARIOstar® /PlusClick Me ArrowValidatedClick Me ArrowValidatedClick Me ArrowValidated
VANTAstarTMClick Me ArrowValidatedClick Me ArrowValidatedClick Me ArrowValidated
SenseIn ReviewClick Me ArrowValidatedIn Review
Analyst® GT/HTClick Me ArrowValidatedClick Me ArrowValidatedClick Me ArrowValidated
Gemini® XPS/EMNot CapableClick Me ArrowValidatedNot Capable
SpectraMax® M2/M2eNot CapableClick Me ArrowValidatedNot Capable
SpectraMax® M5/M5e/FlexStation® 3Not CapableClick Me ArrowValidatedClick Me ArrowValidated
SpectraMax® ParadigmClick Me ArrowValidatedClick Me ArrowContact UsClick Me ArrowContact Us
SpectraMax® iD3/iD5Click Me ArrowValidatedClick Me ArrowValidatedClick Me ArrowValidated
SpectraMax® i3xClick Me ArrowValidatedIn ReviewClick Me ArrowValidated
EnVision®/EnVision® XciteClick Me ArrowValidatedClick Me ArrowValidatedClick Me ArrowValidated
Infinite® M1000/M1000Pro/Safire2TMClick Me ArrowValidatedClick Me ArrowValidatedClick Me ArrowValidated
Infinite® M200Not CapableClick Me ArrowValidatedNot Capable
Infinite® F500Click Me ArrowValidatedClick Me ArrowValidatedClick Me ArrowValidated
Infinite® F200/UltraevolutionClick Me ArrowContact UsClick Me ArrowValidatedClick Me ArrowContact Us
SparkTM 10MClick Me ArrowValidatedClick Me ArrowValidatedClick Me ArrowValidated

What's Included

What You Will Need

The Role of RhoC As a Therapeutic Target

RhoC, a GTPase oncogene, regulates cytoskeleton organization and various cellular functions (such as cell motility, cell polarity, and cell division). Increased expression of RhoC correlates to a poor prognosis in several cancers, including pancreatic ductal carcinoma, breast cancer, skin cancer, ovarian cancer, liver cancer, and head & neck cancer (Thomas et. al, 2019).

Because of RhoC’s roles as an oncogene, it is a promising target in drug discovery. MicroRNAs (miRNAs) are examples of already established RhoC expression regulators (Thomas et. al, 2019). The Transcreener GDP RhoC Assay is an excellent tool for researchers examining RhoC for therapeutic treatments.

TOP